Sensory Evaluation of Oral Nutrition Supplements in Patients at Risk for Mucositis Undergoing Cancer Treatment

PRIMARY OBJECTIVES:

I. To identify two products (one from the creamy shake category and one from the tea
category) with the highest total average score that will be selected to move onto further
testing.

OUTLINE:

Patients receive 10 different nutrition supplements orally (PO) and complete questionnaires
based on each sample in a single session over 60-90 minutes.

Inclusion Criteria:

- Undergoing cancer treatment (chemotherapy, radiotherapy, and/or immunotherapy)

- At risk for mucositis OR with stage I mucositis or esophagitis (i.e. radiotherapy to
the head, neck, esophagus or lung OR treatment with fluorouracil (5-FU) or other
chemotherapeutic agents that are known to cause mucositis or esophagitis) or at risk
for xerostomia

- Within the first 3 weeks of initiation of a new type of therapy

- Able to read and write in English

- Able to provide written informed consent

Exclusion Criteria:

- Food allergy to any component of the supplement

- Inability to taste or smell due to medication or health condition